Perampanel as adjunctive therapy in drug resistant epilepsy in adolescents and children waiting for epilepsy surgery: a multicenter observational study in Thailand
Completed
- Conditions
- The patients with the age between 1 month and 18 years treated with PER and diagnosed with DRE and in the waiting list for epilepsy surgeryPerampanelanti-seizure medicationdrug-resistanttreatment-resistant epilepsy
- Registration Number
- TCTR20220322006
- Lead Sponsor
- Phramongkutklao Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
1. patients with the age between 1 month and 18 years treated with PER, 2. having complete records of baseline seizure frequency for at least 3 months prior to starting PER, 3. taking PER for at least 6 months, 4. diagnosed with DRE and in the waiting list for epilepsy surgery.
Exclusion Criteria
1. patients with generalized epilepsy, 2. patients with epilepsy syndrome.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method seizure reduction 180 days extract from the medical record
- Secondary Outcome Measures
Name Time Method adverse effect, ataxia, mood disturbamce 180 days extract from the medical record